U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. Transparency
  4. FDA-TRACK: Agency-wide Program Performance
  5. FDA-TRACK: National Center for Toxicological Research Dashboard
  1. FDA-TRACK: Agency-wide Program Performance

FDA-TRACK: National Center for Toxicological Research Dashboard

The National Center for Toxicological Research (NCTR), FDA's internationally recognized research center, plays a critical role in the FDA’s mission.  NCTR—in partnership with researchers from elsewhere in FDA, other government agencies, academia, and industry—provides innovative technology, methods development, vital scientific training, and technical expertise. The unique scientific expertise of NCTR is critical in supporting FDA product Centers and their regulatory roles.

Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Explore the progress NCTR is making towards it's strategic priorities below.

Key Projects

I. Opioids and Other Ligands Project

Outreach Measures

I. Total number of GovDelivery Subscriptions (Research Highlights and Science Insights)

Research Publication Measures

I. Percentage of manuscripts submitted to scientific journals in the last 12 months and were accepted for publication


Key Projects


I. Opioids and Other Ligands Project - Molecular Modeling of Opioids and Other Ligands Using a Three-Dimensional Multi-Target Approach Project

Return to top


Outreach Measures

I. Total number of GovDelivery Subscriptions (Research Highlights and Science Insights)

Return to top


Research Publication Measures

I. Number of manuscripts accepted for publication

Return to top


 

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time.

Sign up to receive FDA-TRACK updates

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top